Signal
Innovate UK Awards Papcup and Peripear Non-Dilutive Funding for Diagnostic and AI Solutions
- Category
- Diagnostics · Funding · Global
- Date
- August 11, 2026
- Source
- OVUM
Summary
Papcup and Peripear have each secured 75,000 pounds from Innovate UK's Women in Innovation program. These grants will accelerate the development of Papcup's menstrual blood biosensing diagnostic and Peripear's AI-driven support platforms, targeting critical gaps in non-invasive screening.
The company works in Diagnostics and Digital Health/Telehealth, and this round at Grant/Non-dilutive is new money into that part of the market. Compare it with other recent rounds to see whether prices here are rising or holding steady.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.